We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+11.78%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$234M
AUM Growth
+$73M
(+45%)
Cap. Flow
+$63.6M
Cap. Flow
% of AUM
27.13%
Top 10 Holdings %
Top 10 Hldgs %
47.23%
Holding
82
New
25
Increased
16
Reduced
9
Closed
15
Top Buys
| 1 |
GSK
GSK
|
+$14.8M |
| 2 |
Bionano Genomics
BNGO
|
+$10.2M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
+$7.48M |
| 4 |
UROV
Urovant Sciences Ltd.
UROV
|
+$6.99M |
| 5 |
Biogen
BIIB
|
+$6.64M |
Top Sells
| 1 |
Boston Scientific
BSX
|
+$5.97M |
| 2 |
Elevance Health
ELV
|
+$4.88M |
| 3 |
Icon
ICLR
|
+$4.61M |
| 4 |
Willis Towers Watson
WTW
|
+$3.94M |
| 5 |
Revvity
RVTY
|
+$3.85M |
Sector Composition
| 1 | Healthcare | 92.96% |
| 2 | Financials | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
GSK
GSK
$103B
| $14.6M | 6.24% |
+291,168
| New | +$14.8M |
|
2
Cigna
CI
$80.2B
| $14M | 5.99% |
67,449
+28,249
| +72% | +$5.24M |
|
3
Kura Oncology
KURA
$998M
| $12.7M | 5.43% |
727,258
-110,346
| -13% | -$2.12M |
|
|
AET
4
DELISTED
Aetna Inc
AET
| $12.3M | 5.23% |
60,444
+21,309
| +54% | +$4.16M |
|
5
Sanofi
SNY
$103B
| $11.9M | 5.08% |
266,388
+116,330
| +78% | +$4.97M |
|
6
HCA Healthcare
HCA
$80.7B
| $11.7M | 4.97% |
83,822
-13,408
| -14% | -$1.67M |
|
|
LITS
7
Lite Strategy Inc
LITS
$33.9M
| $9.93M | 4.24% |
115,182
+5,983
| +5% | +$490K |
|
|
8
Alnylam Pharmaceuticals
ALNY
$37.6B
| $9.12M | 3.89% |
104,176
+74,341
| +249% | +$7.48M |
|
|
9
Bionano Genomics
BNGO
$13.2M
| $7.35M | 3.14% |
+2,401
| New | +$10.2M |
|
|
UROV
10
DELISTED
Urovant Sciences Ltd.
UROV
| $7.1M | 3.03% |
+591,454
| New | +$6.99M |
|
|
11
Biogen
BIIB
$28.3B
| $6.82M | 2.91% |
+19,300
| New | +$6.64M |
|
|
12
Elevance Health
ELV
$92.7B
| $6.8M | 2.9% |
24,803
-18,798
| -43% | -$4.88M |
|
13
Humana
HUM
$48.8B
| $6.79M | 2.9% |
20,054
+2,261
| +13% | +$735K |
|
|
PINC
14
DELISTED
Premier
PINC
| $6.61M | 2.82% |
+144,412
| New | +$5.83M |
|
15
Gyre Therapeutics
GYRE
$707M
| $5.94M | 2.53% |
73,464
+10,604
| +17% | +$840K |
|
16
Rigel Pharmaceuticals
RIGL
$762M
| $5.92M | 2.52% |
184,350
+44,488
| +32% | +$1.34M |
|
17
Universal Health Services
UHS
$8.73B
| $5.29M | 2.26% |
41,393
+6,070
| +17% | +$745K |
|
18
Smith & Nephew
SNN
$12.6B
| $4.98M | 2.13% |
+134,388
| New | +$4.85M |
|
19
Novartis
NVS
$287B
| $4.97M | 2.12% |
64,383
+3,003
| +5% | +$222K |
|
|
FOMX
20
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $4.41M | 1.88% |
+770,000
| New | +$4.4M |
|
21
Philips
PHG
$25.3B
| $4.36M | 1.86% |
123,389
-7,686
| -6% | -$263K |
|
|
RVNC
22
DELISTED
Revance Therapeutics, Inc.
RVNC
| $4.08M | 1.74% |
164,353
+63,061
| +62% | +$1.72M |
|
23
Viking Therapeutics
VKTX
$4.41B
| $3.71M | 1.58% |
213,252
-68,052
| -24% | -$810K |
|
|
ALXN
24
DELISTED
Alexion Pharmaceuticals
ALXN
| $3.58M | 1.53% |
+25,785
| New | +$3.23M |
|
|
25
Icon
ICLR
$13B
| $3.57M | 1.52% |
23,198
-32,134
| -58% | -$4.61M |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA